
Medical experts are calling early clinical trial results for a new targeted drug a major breakthrough in treating <b>pancreatic cancer</b>. In tests where patients took the medication alongside chemotherapy, some saw their tumors disappear completely on scans, while nearly all participants experienced a halt in tumor growth. Doctors caution that more long-term studies are needed to determine how long the medication can keep the disease under control. The treatment targets specific genetic mutations that drive tumor growth in aggressive cancers.
This page is a shareable card. Download our app to get the full swipe experience!